Market Product Lead

ABOUT US Basecamp Research is building frontier AI for therapeutic design. We believe the future of medicine lies in reprogramming the body to repair itself, and we design the models and the medicines to teach it how. Our EDEN models are trained on BaseData, the world's largest proprietary genomic dataset, with over 10B genes collected through partnerships in more than 30 countries across all seven continents. This gives our AI models access to genetic diversity that doesn't exist in public databases, and enables EDEN to design cell and gene therapies, enzymes, and peptides directly from information about a disease. Our pipeline of EDEN-designed therapeutics, beginning with in vivo cell therapy, is advancing towards clinical development. In September 2026 we closed an oversubscribed $140M Series C led by S32, with participation from NVIDIA, Anthropic's Anthology Fund, Catalio, European Tech Collective, Firebrand River Capital, King Philanthropies, NATO Innovation Fund, NVentures (NVIDIA's venture arm), Redalpine, Rockefeller Foundation, Singular, Sovereign AI and True Ventures. We have offices and labs in London and Boston, we partner with biopharma companies and academic institutions worldwide, and our work has been recognised by Fast Company's Top 10 Most Innovative Companies in Biotech, the FT-backed Sifted AI100 list of Europe's leading AI startups as well as Barclays Eagle Labs Ones to watch, AI100. At Basecamp Research, we pride ourselves on being a lean collaborative and global team with extremely specialist and unique skills. Our biologists, engineers, ML scientists and field explorers are united by a sense of adventure and the belief that AI, biology and data, will result in new medicines for patients who have few options today. THE ROLE You will own the peptide and protein platform as a commercial product: the market analysis behind it, the target product profiles it is judged against, the decisions about what we build and license first, the go to market strategy and the positioning that partners hear. You will sit between our model and science teams and our business development function, and you will be accountable for the peptide portfolio having a defined buyer, a defensible claim and a credible price. KEY RESPONSIBILITIES MARKET AND COMPETITIVE INTELLIGENCE - Build and maintain a rigorous view of the peptide/protein therapeutics landscape by segment, indication and modality, mechanism trends and delivery technologies. - Track and interpret competitor activity across AI-enabled discovery platforms, peptide/protein-focused biotechs, screening technology providers, and internal pharmaceutical capability, and translate it into implications for our product road map and and go to market execution. - Maintain a live map of deal structures, comparables and valuation benchmarks in platform licensing and co-development, and advise on where our agreements should sit. - Bring the outside in: run structured voice-of-customer work with pharmaceutical R&D leaders, and turn it into prioritised, written requirements rather than anecdotes. TARGET PRODUCT PROFILES AND PROGRAMME DEFINITION - Author and defend target product profiles for internal programmes, specifying which properties are differentiated in the market and define evidence needs. - Translate partner-supplied target product profiles into feasible research plans in collaboration with scientific leadership, including honest assessments of what our platform can and cannot address today. - Define stage gates and go or no-go criteria for peptide programmes, and make the recommendation when a programme should stop. PRODUCTIZATION AND ROADMAP - Decide, on evidence, which platform capabilities become licensable products and in what sequence,